Cue Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cue Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Cue Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $4.81M, a 38.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.81M -$2.98M -38.2% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $5.57M -$2.93M -34.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $6.32M -$2.88M -31.3% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $7.06M -$2.5M -26.2% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $7.79M -$2.11M -21.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $8.5M -$1.38M -14% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $9.2M -$607K -6.19% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $9.56M +$6.19M +184% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $9.9M +$5.38M +119% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $9.88M +$4.23M +74.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $9.81M +$3.04M +44.8% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $3.37M -$4.51M -57.2% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $4.52M -$3.63M -44.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $5.66M +$1.32M +30.4% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $6.77M +$1.44M +26.9% Dec 31, 2020 10-K 2022-03-16
Q3 2020 $7.88M +$1.22M +18.3% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $8.15M +$471K +6.13% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $4.34M -$4.35M -50.1% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $5.34M Dec 31, 2019 10-K 2021-03-09
Q3 2019 $6.66M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $7.68M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $8.69M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.